Abstract

Objective: Total cardiovascular risk determines decisions on treatment strategies in hypertensive patients. The 2007 ESH-ESC guidelines have proposed a new risk stratification scheme. The aim of the study was to assess cardiovascular risk in uncomplicated hypertensive patients comparing approaches of 2007 and 2003 ESH-ESC guidelines. Methods: In 576 non-diabetic essential hypertensive patients without established cardiovascular or renal disease (291 male, 53.0 ± 10.1 years (M ± SD), BMI 29.4 ± 4.4 kg/m2, 38% smokers, BP 156 ± 13/99 ± 8 mmHg, creatinine 94.3 ± 17.4 μmol/l, fasting plasma glucose 5.2 ± 0.6 mmol/l, LDL 3.7 ± 0.9 mmol/l, HDL 1.2 ± 0.3 mmol/l, TG 1.7 ± 0.7 mmol/l) blood chemistry and urine analysis, electrocardiogram, albumin/creatinine urine ratio, echocardiogram, carotid ultrasonogram, plethysmography or applanation tonometry were performed for assessment of total cardiovascular risk according both stratification schemes. Results: According to 2003 ESH-ESC guidelines 8.9, 36.1, 44.5 and 10.2% patients were considered at low, moderate, high and very-high added risk, respectively. Deletion of hsCRP >1 mg/dl from risk factors, taking into account ankle/brachial BP index <0.9 as organ damage (OD) had no significant impact on risk stratification. Use of new dyslipidemia criteria and taking into account signs of impaired carbohydrate metabolism resulted in 8.5 and 8.9% (p < 0.05 for each) increase of high/very high risk group. Equating of metabolic syndrome with OD increased high/very high risk group by 50.2% (p < 0.05). Use of carotid-femoral pulse wave velocity >12 m/s as OD and implementation of new criteria of subclinical kidney damage resulted in 15.4 and 56.4% (p < 0.05 for each) increase of high/very high risk patients. Conclusions: The 2007 ESH-ESC guidelines stratify a higher proportion of hypertensive patients in the high/very high risk groups than do 2003 guidelines. More than 80% uncomplicated hypertensive patients in outpatient hospital clinic have a high/very high added risk according to the 2007 ESH-ESC risk assessment approach. Re-classification of patients in high/very high group is mainly influenced by metabolic syndrome detection and implementation of decreased glomerular filtration rate or creatinine clearance as signs of subclinical organ damage.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.